These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6257214)
1. cAMP and cGMP in the human parotid saliva. Asakura K; Kataura A Arch Otorhinolaryngol; 1980; 226(3):145-54. PubMed ID: 6257214 [TBL] [Abstract][Full Text] [Related]
2. cAMP and cGMP in human parotid saliva: relationships to taste and smell dysfunction, gender, and age. Henkin RI; Velicu I; Papathanassiu A Am J Med Sci; 2007 Dec; 334(6):431-40. PubMed ID: 18091364 [TBL] [Abstract][Full Text] [Related]
3. Etiological relationships of parotid saliva cyclic nucleotides in patients with taste and smell dysfunction. Henkin RI; Velicu I Arch Oral Biol; 2012 Jun; 57(6):670-7. PubMed ID: 22310165 [TBL] [Abstract][Full Text] [Related]
4. Decreased parotid salivary cyclic nucleotides related to smell loss severity in patients with taste and smell dysfunction. Henkin RI; Velicu I Metabolism; 2009 Dec; 58(12):1717-23. PubMed ID: 19631354 [TBL] [Abstract][Full Text] [Related]
5. Electrophoretic protein pattern of human parotid saliva in Sjögren's syndrome and sialosis. Benedek-Spät E; Puskás M; Rajki J Acta Otolaryngol; 1980; 90(3-4):275-82. PubMed ID: 7468188 [TBL] [Abstract][Full Text] [Related]
6. Sialochemical examinations in non-tumorous parotid enlargements. Benedek-Spät E Acta Otolaryngol; 1978; 86(3-4):276-83. PubMed ID: 707068 [TBL] [Abstract][Full Text] [Related]
7. Differences between and within human parotid saliva and nasal mucus cAMP and cGMP in normal subjects and in patients with taste and smell dysfunction. Henkin RI; Velicu I J Oral Pathol Med; 2011 Jul; 40(6):504-9. PubMed ID: 21166719 [TBL] [Abstract][Full Text] [Related]
8. Increased beta 2-microglobulin in both parotid and submandibular/sublingual saliva from patients with Sjögren's syndrome. Mogi M; Kage T; Chino T; Yoshitake K; Harada M Arch Oral Biol; 1994 Oct; 39(10):913-5. PubMed ID: 7741662 [TBL] [Abstract][Full Text] [Related]
9. A sialochemical study on patients with Sjögren's syndrome. Benedek-Spät E; Berényi B; Csiba A Arch Oral Biol; 1975 Oct; 20(10):649-52. PubMed ID: 1059387 [No Abstract] [Full Text] [Related]
10. Progression of salivary gland dysfunction in patients with Sjogren's syndrome. Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458 [TBL] [Abstract][Full Text] [Related]
11. Lysozyme determination in parotid saliva from patients with Sjögren's syndrome. Moutsopoulos HM; Karsh J; Wolf RO; Tarpley TM; Tylenda A; Papadopoulos NM Am J Med; 1980 Jul; 69(1):39-42. PubMed ID: 7386505 [TBL] [Abstract][Full Text] [Related]
12. Alterations of nitrate and nitrite content in saliva, serum, and urine in patients with salivary dysfunction. Xia D; Deng D; Wang S J Oral Pathol Med; 2003 Feb; 32(2):95-9. PubMed ID: 12542832 [TBL] [Abstract][Full Text] [Related]
14. Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Kalk WW; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Nieuw Amerongen AV Ann Rheum Dis; 2001 Dec; 60(12):1110-6. PubMed ID: 11709452 [TBL] [Abstract][Full Text] [Related]
15. The oral component of Sjögren's syndrome. Daniels TE; Silverman S; Michalski JP; Greenspan JS; Sylvester RA; Talal N Oral Surg Oral Med Oral Pathol; 1975 Jun; 39(6):875-85. PubMed ID: 1055974 [TBL] [Abstract][Full Text] [Related]
16. Detection of the soluble form of Fas ligand (sFasL) and sFas in the saliva from patients with Sjögren's syndrome. Nakamura H; Kawakami A; Izumi M; Nakashima T; Takagi Y; Ida H; Nakamura T; Nakamura T; Eguchi K Clin Exp Rheumatol; 2005; 23(6):915. PubMed ID: 16396719 [No Abstract] [Full Text] [Related]
17. Psoriasis, psoriatic arthritis and the possible association with Sjögren's syndrome. Collins P; Rogers S; Jackson J; McCartan B Br J Dermatol; 1992 Mar; 126(3):242-5. PubMed ID: 1554600 [TBL] [Abstract][Full Text] [Related]